3rd Quarter - Report

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Firm
Client
Income
$254,122
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: S. 2529 (119th), H.R. 2821 (119th), S. 355 (119th), H.R. 5371 (119th), H.R. 1 (119th), H.R. 3686 (119th), H.R. 4273 (119th), S. 2491 (119th), S. 2292 (119th)

Pharmacy PHA

H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: SENATE; White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Bills named: H.R. 4958 (119th)

Consumer Issues/Safety/Products CSP

- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1219 (119th)

Manufacturing MAN

- Pharmaceutical Tariffs

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.